The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

NCT: NCT06058585 · Status: RECRUITING · Phase: Phase 3 · Sponsor: The George Institute · Started: 2024-09-04 · Est. Completion: 2029-03-31

Official Summary

CAPTIVATE is an international, multi-centre, Phase III, adaptive, platform, randomised controlled trial in people with chronic kidney disease (CKD). CAPTIVATE aims to find the best treatment, or combination of treatments, that slow the progression of CKD so that fewer people develop kidney failure. CAPTIVATE provides a research platform that allows many treatment-related questions to be answered within a common trial set-up.

Study Design

Interventions

Primary Outcomes

Secondary Outcomes

Trial Locations

More Chronic Kidney Diseases Trials

View all Chronic Kidney Diseases clinical trials

AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.